Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
MGNX MacroGenics, Inc. daily Stock Chart
MGNX [NASD]
MacroGenics, Inc.
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-3.17 Insider Own2.30% Shs Outstand50.57M Perf Week-9.97%
Market Cap264.99M Forward P/E- EPS next Y-2.42 Insider Trans-0.10% Shs Float45.34M Perf Month-32.65%
Income-151.80M PEG- EPS next Q-1.02 Inst Own95.60% Short Float7.80% Perf Quarter-52.10%
Sales64.20M P/S4.13 EPS this Y24.60% Inst Trans0.06% Short Ratio6.72 Perf Half Y-57.29%
Book/sh4.71 P/B1.11 EPS next Y33.10% ROA-41.50% Target Price17.82 Perf Year-72.75%
Cash/sh4.27 P/C1.23 EPS next 5Y- ROE-55.20% 52W Range4.04 - 19.80 Perf YTD-51.84%
Dividend- P/FCF- EPS past 5Y-17.70% ROI-76.80% 52W High-73.54% Beta2.17
Dividend %- Quick Ratio5.30 Sales past 5Y6.10% Gross Margin- 52W Low29.70% ATR0.76
Employees384 Current Ratio5.30 Sales Q/Q59.50% Oper. Margin- RSI (14)37.90 Volatility8.03% 13.07%
OptionableYes Debt/Eq0.00 EPS Q/Q41.10% Profit Margin- Rel Volume0.69 Prev Close5.41
ShortableYes LT Debt/Eq0.00 EarningsFeb 25 AMC Payout- Avg Volume526.48K Price5.24
Recom2.00 SMA20-7.38% SMA50-36.93% SMA200-53.65% Volume363,596 Change-3.14%
Mar-04-20Initiated Barclays Underweight $8
Dec-19-19Initiated Cantor Fitzgerald Overweight
Dec-18-19Initiated Cantor Fitzgerald Overweight
Nov-21-19Downgrade Morgan Stanley Equal-Weight → Underweight $17 → $6
Nov-20-19Resumed Guggenheim Neutral
May-03-19Upgrade Wedbush Neutral → Outperform $26
Apr-12-19Initiated Guggenheim Neutral
Feb-07-19Upgrade Citigroup Sell → Buy
Feb-07-19Downgrade Wedbush Outperform → Neutral
Feb-06-19Upgrade Raymond James Underperform → Mkt Perform
Feb-04-19Downgrade Citigroup Neutral → Sell $10
Dec-10-18Downgrade Raymond James Outperform → Underperform
Sep-10-18Resumed BTIG Research Buy $30
May-31-18Initiated Evercore ISI Outperform $33
Mar-05-18Initiated H.C. Wainwright Buy $38
Mar-31-17Initiated Raymond James Outperform $26
Mar-02-17Initiated Instinet Buy $41
Dec-20-16Initiated SunTrust Buy $30
Aug-04-16Downgrade Citigroup Buy → Neutral
Oct-19-15Upgrade Citigroup Neutral → Buy
Mar-16-20 06:16PM  These Greater Washington firms took the biggest dives Monday on Wall Street American City Business Journals -28.00%
Mar-10-20 01:50AM  Edited Transcript of MGNX earnings conference call or presentation 25-Feb-20 9:30pm GMT Thomson Reuters StreetEvents +10.70%
Mar-04-20 05:00PM  MacroGenics Announces Departure of Chief Medical Officer GlobeNewswire
Mar-02-20 08:45AM  These local companies have taken the biggest hits on Wall Street during current sell-off American City Business Journals
Feb-27-20 10:30AM  MacroGenics, Inc. Consensus Forecasts Have Become A Little Darker Since Its Latest Report Simply Wall St. -15.65%
07:30AM  MacroGenics to Participate in Upcoming Investor Conferences GlobeNewswire
Feb-25-20 04:01PM  MacroGenics Provides Update on Corporate Progress and 2019 Financial Results GlobeNewswire
Feb-24-20 02:48PM  Some MacroGenics (NASDAQ:MGNX) Shareholders Have Copped A Big 67% Share Price Drop Simply Wall St.
Feb-13-20 07:30AM  MacroGenics Announces Date of Fourth Quarter and Full Year 2019 Financial Results Conference Call GlobeNewswire
Feb-10-20 07:30AM  MacroGenics to Participate in Upcoming Investor Conferences GlobeNewswire +5.78%
Jan-14-20 03:12PM  Eli Lilly ends deal with NextCure worth up to $1.4B for the local biotech American City Business Journals
Jan-13-20 07:30AM  MacroGenics to Present at the J.P. Morgan Healthcare Conference GlobeNewswire
Jan-09-20 04:30PM  MacroGenics Outlines Corporate Priorities for 2020 GlobeNewswire
Jan-06-20 05:14PM  Intrexon will take the name of its subsidiary. That company just scored orphan status for a rare cancer drug. American City Business Journals
Dec-19-19 12:00PM  MacroGenics Announces Submission of Margetuximab Biologics License Application to U.S. FDA GlobeNewswire
Dec-11-19 10:00AM  MacroGenics Presents Results from the SOPHIA Study of Margetuximab in Patients with HER2-Positive Metastatic Breast Cancer at the San Antonio Breast Cancer Symposium GlobeNewswire
Dec-09-19 03:05PM  MacroGenics Presents Flotetuzumab Data in Patients with Primary Induction Failure and Early Relapsed Acute Myeloid Leukemia at the 2019 ASH Annual Meeting GlobeNewswire
Dec-07-19 08:35AM  The Week Ahead In Biotech: ASH Presentations Pick Up Steam, Correvio Awaits Adcom Ruling Benzinga
Nov-15-19 12:02PM  We Think MacroGenics (NASDAQ:MGNX) Needs To Drive Business Growth Carefully Simply Wall St.
Nov-13-19 04:55PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of MacroGenics, Inc. - MGNX ACCESSWIRE
Nov-12-19 01:45PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SNDL, MGNX and OLLI ACCESSWIRE
12:45PM  FILING FIRM ANNOUNCES DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
10:59AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MGNX, OSTK, RUHN and REZI GlobeNewswire
10:29AM  TUESDAY DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against MacroGenics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
10:00AM  DEADLINE ALERT - MacroGenics, Inc. (MGNX) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: November 12, 2019 PR Newswire
09:36AM  CLASS ACTION UPDATE for SNDL, DBX, MGNX and WTRH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
07:37AM  MacroGenics Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In MacroGenics, Inc. To Contact The Firm Newsfile
03:29AM  Edited Transcript of MGNX earnings conference call or presentation 6-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
02:00AM  MGNX DEADLINE TODAY: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts MacroGenics (MGNX) Investors of Todays Deadline to Move for Lead Plaintiff ACCESSWIRE
Nov-11-19 03:35PM  CLASS ACTION UPDATE for SNDL, MGNX and WTRH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
03:21PM  MacroGenics Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In MacroGenics, Inc. To Contact The Firm Newsfile
01:45PM  FILING FIRM ANNOUNCES DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
12:15PM  SHAREHOLDER ALERT: UNIT MGNX QUAD: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
12:00PM  MGNX INVESTOR DEADLINE TOMORROW: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Motion for Lead Plaintiff in a Securities Class Action Lawsuit Against MacroGenics, Inc. ACCESSWIRE
10:40AM  DEADLINE ALERT - MacroGenics, Inc. (MGNX) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: November 12, 2019 ACCESSWIRE
09:41AM  SHAREHOLDER ALERT: PUMP MGNX VRAY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
07:10AM  FINAL DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds MacroGenics (MGNX) Investors of Tomorrows Lead Plaintiff Deadline, Encourages Investors with Significant Losses to Contact the Firm ACCESSWIRE
Nov-10-19 12:00PM  2-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds MacroGenics (MGNX) Investors of November 12th Lead Plaintiff Deadline, Encourages Investors with Significant Losses to Contact the Firm GlobeNewswire
10:30AM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of MGNX, SDC and CC ACCESSWIRE
Nov-09-19 07:35PM  3-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds MacroGenics (MGNX) Investors of November 12th Lead Plaintiff Deadline, Encourages Investors with Significant Losses to Contact the Firm ACCESSWIRE
11:52AM  ROSEN, A LEADING GLOBAL LAW FIRM, Reminds MacroGenics, Inc. Investors of Important November 12th Deadline in Securities Class Action MGNX GlobeNewswire
Nov-08-19 08:15PM  4-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds MacroGenics (MGNX) Investors of November 12th Lead Plaintiff Deadline, Encourages Investors with Significant Losses to Contact the Firm ACCESSWIRE
04:59PM  MGNX NOTICE: Zhang Investor Law Reminds Investors of November 12 Deadline in Securities Class Action Lawsuit Against MacroGenics, Inc.- MGNX GlobeNewswire
03:00PM  DEADLINE ALERT - MacroGenics, Inc. (MGNX) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: November 12, 2019 GlobeNewswire
02:15PM  CLASS ACTION UPDATE for SEE, MGNX and VRAY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
01:00PM  4-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
11:20AM  SHAREHOLDER ALERT: SEE UNIT MGNX UBER: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
10:40AM  SHAREHOLDER ALERT - MacroGenics, Inc. (MGNX) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Deadline: November 12, 2019 ACCESSWIRE
10:23AM  MacroGenics Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In MacroGenics, Inc. To Contact The Firm Newsfile
09:50AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MGNX, CVET and MYGN ACCESSWIRE
Nov-07-19 08:05PM  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages MacroGenics (MGNX) Investors With Significant Losses to Contact Its Attorneys, 5-Day Application Deadline is Approaching in Securities Class Action ACCESSWIRE
05:30PM  SHAREHOLDER ALERT: COF MGNX CVET: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
04:45PM  MacroGenics to Participate in Upcoming Investor Conferences GlobeNewswire
04:39PM  INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in MGNX, ERI, and SNDL of Filing Deadlines GlobeNewswire
02:15PM  CLASS ACTION UPDATE for UNIT, MGNX and MTCH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
01:30PM  5-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
09:25AM  CLASS ACTION UPDATE for PUMP, MGNX, IRBT and TWTR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Nov-06-19 07:50PM  HAGENS BERMAN, SHAREHOLDER ADVOCATES, Encourages MacroGenics (MGNX) Investors With Significant Losses to Contact Its Attorneys, 6-Day Application Deadline is Approaching ACCESSWIRE
06:35PM  MacroGenics (MGNX) Reports Q3 Loss, Lags Revenue Estimates Zacks
06:00PM  DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against MacroGenics, Inc. and Encourages Investors to Contact the Firm PR Newswire
04:01PM  MacroGenics Provides Update on Corporate Progress and Third Quarter 2019 Financial Results GlobeNewswire
03:30PM  SHAREHOLDER ALERT: SNDL MGNX TME: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
02:00PM  SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
01:30PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of MacroGenics, Inc. - MGNX ACCESSWIRE
12:15PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MGNX, TME and UBER ACCESSWIRE
10:39AM  SHAREHOLDER ALERT - MacroGenics, Inc. (MGNX) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: November 12, 2019 ACCESSWIRE
09:30AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PUMP, MGNX, TME and UBER GlobeNewswire
09:12AM  MacroGenics Announces Flotetuzumab Presentations at the ASH Annual Meeting 2019 GlobeNewswire
Nov-05-19 08:00PM  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages MacroGenics (MGNX) Investors With Significant Losses to Contact Its Attorneys Now, 7-Day Application Deadline is Approaching GlobeNewswire
04:00PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of UNIT, MGNX and MO ACCESSWIRE
03:15PM  FIRST FIRM TO FILE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
11:00AM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of MDP, MGNX and CVET ACCESSWIRE
10:00AM  Scott+Scott Attorneys at Law LLP Reminds Investors of Securities Class Action Against MacroGenics, Inc. (MGNX) and November 12 Deadline Business Wire
Nov-04-19 08:05PM  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Notifies MacroGenics (MGNX) Investors of 8-Day Application Deadline, Encourages Investors Who Suffered Significant Losses to Contact Firm Now ACCESSWIRE
04:00PM  IMPORTANT REMINDER FOR MACROGENICS, INC. INVESTORS: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District for the District of Maryland against MacroGenics, Inc. GlobeNewswire
03:57PM  UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
03:10PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FTCH, UNIT and MGNX ACCESSWIRE
12:45PM  FINAL DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
12:35PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of MacroGenics, Inc. - MGNX GlobeNewswire
12:20PM  CLASS ACTION UPDATE for SNDL, MGNX and OSTK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
10:38AM  SHAREHOLDER ALERT - MacroGenics, Inc. (MGNX) - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action and Lead Plaintiff Deadline: November 12, 2019 ACCESSWIRE
09:37AM  3 Medical Product Stocks Likely to Beat This Earnings Season Zacks
Nov-01-19 03:35PM  SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
03:00PM  Shareholder Alert - Greenlane Holdings, Inc. (GNLN), MacroGenics, Inc. (MGNX) & ViewRay, Inc. (VRAY)  - Bronstein, Gewirtz & Grossman, LLC Class Actions GlobeNewswire
01:11PM  INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in MGNX, ERI, and SNDL of Filing Deadlines GlobeNewswire
12:14PM  CLASS ACTION UPDATE for MGNX, MO, MTCH and TWTR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
11:29AM  Pawar Law Group Reminds Investors of Deadline in Securities Class Action Lawsuit Against MacroGenics, Inc.- MGNX GlobeNewswire
10:10AM  Investor Alert - Greenlane Holdings, Inc. (GNLN), MacroGenics, Inc. (MGNX) & ViewRay, Inc. (VRAY) - Bronstein, Gewirtz & Grossman, LLC Class Action Announcement ACCESSWIRE
Oct-31-19 01:00PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of MGNX, CC and TEUM ACCESSWIRE
12:45PM  FIRST LAW FIRM TO FILE: The Schall Law Firm Files a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
11:40AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of MacroGenics, Inc. - MGNX ACCESSWIRE
09:41AM  CLASS ACTION UPDATE for ADTN, MDP, MGNX and VRAY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
07:00AM  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds MacroGenics (MGNX) Investors of Securities Class Action: Encourages Investors Who Have Suffered Losses to Contact Firm GlobeNewswire
Oct-30-19 05:25PM  CLASS ACTION UPDATE for MGNX, MTCH and MYGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
04:05PM  MacroGenics Announces Date of Third Quarter 2019 Financial Results Conference Call GlobeNewswire
04:00PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MacroGenics, ViewRay, Cadence Bancorp, and ProPetro and Encourages Investors to Contact the Firm GlobeNewswire
02:25PM  SHAREHOLDER ALERT: ADTN MGNX OSTK: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
01:10PM  FIRST LAW FIRM TO FILE: The Schall Law Firm Files a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
10:45AM  SHAREHOLDER ALERT: COF MDP MGNX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
10:34AM  MacroGenics (MGNX) Expected to Beat Earnings Estimates: Should You Buy? Zacks
MacroGenics, Inc., a biopharmaceutical company, discovers and develops antibody-based therapeutics for the treatment of cancer in the United States. Its pipeline of immuno-oncology product candidates includes Margetuximab, a monoclonal antibody, which is in Phase III clinical trial that targets HER2-expressing tumors, such as various breast and gastroesophageal cancers. The company is also developing Flotetuzumab, a DART molecule that recognizes CD123 and CD3 for treating acute myeloid leukemia; MGA012, an investigational monoclonal antibody targeting PD-1; MGD013, a monoclonal antibody that targets the PD-1 and lymphocyte-activation gene 3; MGD019, a monoclonal antibody that targets the immune checkpoints PD-1 and cytotoxic T-lymphocyte-associated protein 4; and Enoblituzumab, a monoclonal antibody that targets B7-H3. In addition, the company is developing combination of MGD009 and MGA012; MGC018, an antibody drug conjugate, which targets solid tumors expressing B7-H3; and MGD014, a DART molecule that targets envelope protein of human immunodeficiency virus infected cells and T cells. It has strategic collaborations with Incyte Corporation; Zai Lab Limited; and I-Mab Biopharma. MacroGenics, Inc. was founded in 2000 and is headquartered in Rockville, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Risser Eric BlasiusSr VP & Chief Business OfficerMar 13Option Exercise0.946,0005,64038,468Mar 17 04:09 PM
Koenig ScottPresident and CEOMar 11Option Exercise0.94133,163125,173943,103Mar 13 04:15 PM
Karrels JamesSVP, CFO and SecretaryMar 06Option Exercise0.944,4734,205152,460Mar 09 04:39 PM
Risser Eric BlasiusSr VP & Chief Business OfficerFeb 20Option Exercise0.9450047032,968Feb 21 04:44 PM
Risser Eric BlasiusSr VP & Chief Business OfficerFeb 20Sale10.845005,42032,468Feb 21 04:44 PM
Risser Eric BlasiusSr VP & Chief Business OfficerFeb 05Option Exercise0.9462358633,091Feb 06 04:41 PM
Risser Eric BlasiusSr VP & Chief Business OfficerFeb 05Sale10.006236,23032,468Feb 06 04:41 PM
Risser Eric BlasiusSr VP & Chief Business OfficerFeb 04Option Exercise0.94302832,498Feb 06 04:41 PM
Risser Eric BlasiusSr VP & Chief Business OfficerFeb 04Sale10.003030032,468Feb 06 04:41 PM
Karrels JamesSVP, CFO and SecretaryJan 30Option Exercise0.9412,50011,750147,987Jan 31 04:45 PM
Risser Eric BlasiusSr VP & Chief Business OfficerSep 27Option Exercise0.941,6621,56232,468Oct 03 04:33 PM
Risser Eric BlasiusSr VP & Chief Business OfficerMay 22Option Exercise0.941,00094031,806May 22 04:21 PM
Risser Eric BlasiusSr VP & Chief Business OfficerMay 22Sale19.031,00019,02630,806May 22 04:21 PM
Risser Eric BlasiusSr VP & Chief Business OfficerMay 20Option Exercise0.943,0002,82033,806May 22 04:21 PM
Risser Eric BlasiusSr VP & Chief Business OfficerMay 20Sale18.383,00055,13130,806May 22 04:21 PM
open in yahoo | open in reuters | open in google